Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial

Annette M. Lim, Danny Rischin, Richard Fisher, Hongbin Cao, Kathleen Kwok, Daniel D. Truong, Grant A. McArthur, Richard J. Young, Amato J. Giaccia, Lester Peters,

Clinical Cancer Research · 2011 · 52 citations · 21 references

DOIFull text

Open access

Abstract

We found no evidence that high plasma OPN levels were associated with an adverse prognosis in HNSCC, or were predictive of benefit with hypoxia targeting therapy.

References

21